ACM
AUPH icon

Altium Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Altium Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-144,000
Closed -$3.19M – 140
2021
Q3 		$3.19M Sell
144,000
-184,908
-56% -$2.93M 0.84% 52
2021
Q2 		$4.26M Sell
328,908
-80,000
-20% -$1.02M 0.99% 35
2021
Q1 		$5.31M Buy
408,908
+114,991
+39% +$1.67M 1.47% 18
2020
Q4 		$4.07M Buy
+293,917
New +$4.28M 1.52% 23

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Altium Capital Management's AUPH Position: Q4 2021 in Review

Altium Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2021, closing a stake of 144,000 shares — an estimated $3.19M sold.

Altium Capital Management first reported a position in AUPH in Q4 2020 and held it in 4 quarters. The position peaked at $5.31M in Q1 2021. 190 funds tracked by Wall St. Rank hold AUPH as of Q4 2021.

  • Altium Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Altium Capital Management sold 144,000 Aurinia Pharmaceuticals shares in Q4 2021, an estimated $3.19M.
  • Altium Capital Management first reported a position in Aurinia Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Altium Capital Management's Aurinia Pharmaceuticals position peaked at $5.31M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2021.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.